| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $16.05B | -5.7% |
| Cost of Revenue | $13.19B | -9.0% |
| R&D Expense | $58.0M | -26.6% |
| SG&A Expense | $2.77B | -4.8% |
| Interest Expense | $122.0M | +29.8% |
| Pre-tax Income | -$168.0M | +80.3% |
| Income Tax | $172.0M | -67.2% |
| Net Income | -$340.0M | +75.3% |
| EPS (Basic) | -$1.48 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.55B | -15.9% |
| Accounts Receivable | $1.60B | +5.0% |
| Current Assets | $4.75B | -4.4% |
| Total Assets | $10.59B | -7.6% |
| Current Liabilities | $4.59B | -5.7% |
| Long-term Debt | $2.90B | -3.3% |
| Total Liabilities | $9.47B | -5.3% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $454.0M | -41.9% |
| Investing Cash Flow | -$553.0M | +33.8% |
| Financing Cash Flow | -$170.0M | -20.6% |
| +75.6% |
| EPS (Diluted) | -$1.48 | +75.6% |
| Stockholders' Equity |
| $1.01B |
| -25.6% |